Top 18 Grey Wolf Therapeutics investors
The most complete profiles first. Showing 18 of 18.
Brent AhrensVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Relievant Medsystems, Grey Wolf Therapeutics, Abyrx, Semnur Pharmaceuticals and 12 more
Verified email available
Eric YoungVerified
Venture Capital, Founder, Investor · United Kingdom
SeedSeries BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Filanet, Hallo and 85 more
Verified email available
Guy RussoVerified
Venture Capital, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Jared NewmanVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Joydeep BhattacharyyaVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceCybersecurityPortfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more
Verified email available
Laura ChauVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Olivier LitzkaVerified
Venture Capital, Private Equity Firm, Investor · Germany
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more
Verified email available
Tim ShannonVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 83 more
Verified email available
Hootan RashidifardVerified
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Verified email available
Alexandre Foulon
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsDeepTechPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Arnaud Faure
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Mayeul Caron
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Nandu Anilal
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Pierre
Venture Capital, Private Equity Firm, Investor · France
Series BHealth CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Rayfe Gaspar
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AAdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
Byron Ling
Venture Capital · United States
AdvertisingHealth CareE-commerceMessagingPortfolio: Node, OncoResponse, Hallo, SeeTree and 81 more
Contact details available
David Robin
Venture Capital, Private Equity Firm · France
Health CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
Pierre Morisseau
Venture Capital, Private Equity Firm · France
Health CareWearablesHospitalsWellnessPortfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Relievant Medsystems11
- Mantra Health11
- Resemble AI10
- Bumped10
- Commonwealth Labs10
- Join Digital10
- SeeTree10
- JOOR10
- Coinmine10
- Roman10
- Node10
Frequently asked questions
How many Grey Wolf Therapeutics investors are on Angel Roster?
Angel Roster lists 18 Grey Wolf Therapeutics investors. 9 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (14) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Grey Wolf Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (14), Series A (9) and Seed (1).
Where are Grey Wolf Therapeutics investors based?
Most are based in the United States (10), France (6) and Germany (1).
Which companies have Grey Wolf Therapeutics investors backed?
The most-backed portfolio companies among them are Relievant Medsystems (11), Mantra Health (11), Resemble AI (10), Bumped (10) and Commonwealth Labs (10).
How do I contact Grey Wolf Therapeutics investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.